76 filings
Page 3 of 4
8-K
7hv9eik
6 Aug 20
Amneal Reports Second Quarter 2020 Financial Results
6:09am
8-K
wp598gpq0gsxyrpn
4 Aug 20
Departure of Directors or Certain Officers
4:16pm
8-K
5ba gllit6ukdx
11 May 20
Amneal Reports First Quarter 2020 Financial Results
6:47am
8-K
iurrbe 4x4oaq
8 May 20
Departure of Directors or Certain Officers
7:43am
8-K/A
0ymrb499wyi3mkp7n zv
17 Apr 20
Independent Auditor’s Report
4:05pm
8-K
8emtjs3ql69l9islb
12 Mar 20
Amneal Pharmaceuticals Appoints Tasos Konidaris as Senior Vice President, Chief Financial Officer
5:19pm
8-K
wofurq0
26 Feb 20
Departure of Directors or Certain Officers
4:55pm
8-K
l6mshbsga8iq4v3zvs
26 Feb 20
Amneal Reports Fourth Quarter and Full Year 2019 Financial Results
6:50am
8-K/A
cqpz50ns6kvqod 93fe
20 Feb 20
Departure of Directors or Certain Officers
4:49pm
8-K/A
a6b4j7vn
20 Feb 20
Departure of Directors or Certain Officers
4:47pm
8-K
0ocrx7
4 Feb 20
Entry into a Material Definitive Agreement
12:00am
8-K
b4rai4k6
15 Jan 20
Regulation FD Disclosure
10:32am
8-K
c4x29evv
16 Dec 19
Amneal Appoints Jeff George, John Kiely and Shlomo Yanai to Board of Directors
4:50pm
8-K
dxw5yl6wjlm4lrcr6c
10 Dec 19
Amneal to Acquire Majority Interest in AvKARE, Enhancing Access
4:51pm
8-K
o26gogbklp
6 Nov 19
Amneal Reports Third Quarter 2019 Financial Results
6:54am
8-K
ij4y9
11 Oct 19
Submission of Matters to a Vote of Security Holders
12:07pm
8-K
3fi4fms 4c0
5 Aug 19
Amneal Reports Second Quarter 2019 Financial Results
6:20am
8-K
jssnwpa
5 Aug 19
Paul Meister Elected Chairman of the Board
6:13am
8-K
q7j gctwy
10 Jul 19
Amneal Pharmaceuticals Announces Restructuring and Costs Savings Plan to Improve Operations and Position the Company for Future Growth
4:52pm
8-K
0dqv3
9 May 19
Departure of Directors or Certain Officers
4:43pm